Chronic Medication Denied by Medical Scheme in SA

For South Africans managing long-term conditions, reliable access to chronic medication is not a luxury — it is a medical necessity. Yet medical scheme denials of chronic medication are among the most common complaints received by the Council for Medical Schemes (CMS). If your scheme has denied funding for your chronic medication, the law gives you meaningful tools to push back.

The Chronic Disease List (CDL) and Your Rights

The Chronic Disease List is a component of South Africa's Prescribed Minimum Benefits (PMBs) under the Medical Schemes Act 131 of 1998. It defines 25 (functionally 26) chronic conditions for which all medical schemes must fund ongoing treatment, regardless of plan tier or annual benefit limits:

• Addison's disease
• Asthma
• Bipolar disorder
• Cancer (defined oncology protocols)
• Cardiac failure
• Coronary artery disease
• Chronic obstructive pulmonary disease (COPD)
• Crohn's disease
• Diabetes mellitus Type 1 and Type 2
• Dysrhythmias
• Epilepsy
• Glaucoma
• Haemophilia
• HIV/AIDS
• Hyperlipidaemia
• Hypertension
• Hypothyroidism
• Multiple sclerosis
• Parkinson's disease
• Rheumatoid arthritis
• Schizophrenia
• Systemic lupus erythematosus (SLE)
• Ulcerative colitis

If your condition is on this list, the scheme must fund appropriate medication — it is not discretionary.

What Is a Formulary and Why Does It Matter?

A formulary is your scheme's approved list of medicines for CDL conditions. Schemes design their formularies to include cost-effective, evidence-based treatments — typically including generics and preferred branded products. The formulary is often tiered:

• First-line: generics and established branded products funded without restriction
• Second-line: funded with prior authorisation or after first-line failure
• Excluded: not funded — the scheme expects you to use an alternative

The problem arises when your doctor prescribes a medication that is not on the formulary, or a higher-line option the scheme believes you have not "failed" first.

Common Reasons Chronic Medication Claims Are Denied

Medication not on the formulary: The most frequent scenario. Your specialist prescribes a specific statin, blood pressure medication, insulin formulation, or biologic — and the scheme says it is not covered.

Chronic benefit registration not completed: To access CDL chronic benefits, most schemes require you to register the condition. Without registration, claims are processed against your day-to-day benefits (which may be exhausted) rather than the unlimited CDL benefit. If the scheme denies medication because you have not registered, the fix is registration — not an appeal.

Not yet tried the first-line option: The scheme may fund a second-line or specialist medication only after the patient has tried and failed the first-line formulary option. If your doctor prescribed the second-line medication from the outset, the scheme may demand trial of the first-line drug first.

Generic substitution: Schemes routinely substitute branded medications with generics. In most cases, generics are bioequivalent and appropriate. However, in some cases (specific epilepsy medications, narrow therapeutic index drugs), substitution is clinically problematic.

Quantity or refill disputes: The scheme may deny a prescription because of quantity limits (e.g., a 90-day supply vs the standard 30-day dispensing), or because you are refilling early.

Off-formulary biologic drugs: Rheumatoid arthritis, Crohn's disease, and other conditions now have biologic treatment options (e.g., adalimumab, infliximab). These are expensive, and schemes may deny them if the submission does not meet their prior authorisation criteria.

How to Appeal a Chronic Medication Denial

Step 1 — Register your CDL condition

If you have not already registered your chronic condition with the scheme, do so immediately. Each scheme has a registration process — typically involving a doctor's certificate confirming the diagnosis. Registration unlocks your CDL benefit.

Step 2 — Request written denial reasons

Get the specific formulary item denied, the reason, and the formulary alternative offered, in writing.

Step 3 — Get a strong doctor's motivation

Your specialist must write a letter explaining:

• Your specific diagnosis and severity
• Why the prescribed medication is medically necessary
• Why the formulary alternative is inadequate (if applicable — e.g., you tried the first-line drug and had adverse effects, or the alternative is contraindicated given another condition)
• Reference to the CDL condition and PMB entitlement

Step 4 — Submit the internal appeal

Write to the scheme's pharmacy benefit management team or principal officer. Cite:

• The CDL condition
• The Medical Schemes Act 131 of 1998 and PMB Regulations
• The requirement to fund appropriate treatment, not just the cheapest option
• Your doctor's clinical motivation

Step 5 — CMS complaint

If the scheme does not resolve the matter within 30 days:

• File a complaint at medicalschemes.com
• Email: complaints@medicalschemes.com

Narrow Therapeutic Index Medications

Medications with a narrow therapeutic index — where small changes in blood levels can cause toxicity or treatment failure — include certain anti-epileptic drugs (phenytoin, carbamazepine) and some cardiac drugs. Generic substitution for these medications can be clinically inappropriate. If your doctor has documented a clinical reason to avoid generic substitution for a narrow therapeutic index drug, include this in your appeal with reference to the specific drug and clinical guideline.

Fight Back With ClaimBack

ClaimBack's free AI tool drafts a professional appeal letter in minutes, tailored to your insurer and denial reason. Don't let a denial be the final word.

Fight your denial at ClaimBack →

Related Reading:

• How to Write an Insurance Appeal Letter
• What Is Medical Necessity?
• Internal vs External Insurance Appeal